Literature DB >> 1092163

Pharmacologic and clinical control of antiarrhythmic drugs.

J T Bigger.   

Abstract

Knowledge of pharmacokinetics and pharmacodynamics is a powerful tool for controlling cardiac arrhythmias with drugs even though antiarrhythmic drugs are potentially quite toxic. If the diagnosis and drug selection are correct at the outset of therapy, the clinician can use his knowledge of pharmacokinetics to achieve arrhythmia control with a minimum of personal effort and risk to his patient.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092163     DOI: 10.1016/0002-9343(75)90120-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  The clinical pharmacology of lidocaine as an antiarrhythmic drug.

Authors: 
Journal:  West J Med       Date:  1976-01

2.  Serum procainamide levels as therapeutic guides.

Authors:  J Koch-Weser
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Correlation between serum concentration and pharmacological effect on atrioventricular conduction time of the antiarrhythmic drug propafenone.

Authors:  K Keller; G Meyer-Estorf; O A Beck; H Hochrein
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

4.  Adverse reactions to procainamide.

Authors:  D H Lawson; H Jick
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.